Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf Herman Fridman

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Trends in Immunology|December 27, 2015
TLS in Tumors: What Lies WithinCatherine Sautès-Fridman, Wolf Herman Fridman
Frontiers in Immunology|June 9, 2020
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune CheckpointJörg Wischhusen, Ignacio Melero, Wolf Herman Fridman
Cancer Research|March 3, 2007
The adaptive immunologic microenvironment in colorectal cancer: a novel perspectiveJérôme Galon, Wolf-Herman Fridman, Franck Pagès
Bulletin Du Cancer|April 15, 2020
[Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses]Wolf Herman Fridman, Florent Petitprez, Catherine Sautes-Fridman
Aging|April 18, 2015
Molecular subtypes and prognosis in RCCBenoit Beuselinck, Wolf Herman Fridman, Jessica Zucman-Rossi
Oncoimmunology|June 22, 2012
Tumor microenvironment in NSCLC suppresses NK cells functionIsabelle Cremer, Wolf Herman Fridman, Catherine Sautès-Fridman
Seminars in Immunopathology|April 5, 2011
The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Blood|May 5, 2010
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune responseRiad Abès, Emmanuelle Gélizé, Wolf Herman Fridman, et al.
Immunology Letters|August 1, 2025
B cells are major players in cancer immunityThéo Bouloudani, Guilhem Pupier, Catherine Sautès-Fridman, et al.
Nature Reviews. Cancer|March 16, 2012
The immune contexture in human tumours: impact on clinical outcomeWolf Herman Fridman, Franck Pagès, Catherine Sautès-Fridman, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Trends in Immunology|December 27, 2015
TLS in Tumors: What Lies WithinCatherine Sautès-Fridman, Wolf Herman Fridman
Frontiers in Immunology|June 9, 2020
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune CheckpointJörg Wischhusen, Ignacio Melero, Wolf Herman Fridman
Cancer Research|March 3, 2007
The adaptive immunologic microenvironment in colorectal cancer: a novel perspectiveJérôme Galon, Wolf-Herman Fridman, Franck Pagès
Bulletin Du Cancer|April 15, 2020
[Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses]Wolf Herman Fridman, Florent Petitprez, Catherine Sautes-Fridman
Aging|April 18, 2015
Molecular subtypes and prognosis in RCCBenoit Beuselinck, Wolf Herman Fridman, Jessica Zucman-Rossi
Oncoimmunology|June 22, 2012
Tumor microenvironment in NSCLC suppresses NK cells functionIsabelle Cremer, Wolf Herman Fridman, Catherine Sautès-Fridman
Seminars in Immunopathology|April 5, 2011
The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsGabriela Bindea, Bernhard Mlecnik, Wolf-Herman Fridman, et al.
Blood|May 5, 2010
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune responseRiad Abès, Emmanuelle Gélizé, Wolf Herman Fridman, et al.
Immunology Letters|August 1, 2025
B cells are major players in cancer immunityThéo Bouloudani, Guilhem Pupier, Catherine Sautès-Fridman, et al.
Nature Reviews. Cancer|March 16, 2012
The immune contexture in human tumours: impact on clinical outcomeWolf Herman Fridman, Franck Pagès, Catherine Sautès-Fridman, et al.
Pageof 11